BSE Announcement

360 One Wam will hold a meeting of the Board of Directors of the Company on 16 July 2026.

Adani Enterprises and Dioxycle, a French clean-technology company specialising in chemical manufacturing, today announced a long-term partnership to develop and scale low-carbon chemical production in India.

The initiative will begin with a pilot facility at an Adani Group's site to produce formic acid using captured carbon dioxide and renewable electricity. Following successful validation, the partners plan to scale the technology for commercial manufacturing.

Formic acid and its derivatives are widely used across industries including textiles, agriculture and manufacturing. The project aims to demonstrate how captured carbon emissions can be converted into valuable products using clean energy.

The partnership combines Dioxycle's electrically driven chemical manufacturing technology with Adani Group's clean-energy capabilities, infrastructure platform and project execution expertise to create a new model for sustainable and cost-competitive chemical production.

Adani Green Energy announced that Care ESG Ratings has assigned an Environmental, Social and Governance (ESG) rating of 87.3 to the Company for FY26.

Advait Energy Transitions has received a turnkey contract worth Rs 75.56 crore from Paschim Gujarat Vij Company for conversion of existing 11 kV HT & LT line network into underground cable network at Udyognagar - Porbandar Circle under PGVCL (Package 61)

Affordable Robotic & Automation will hold a meeting of the Board of Directors of the Company on 17 July 2026.

Agri-Tech (India) will hold a meeting of the Board of Directors of the Company on 15 July 2026.

Alok Industries will hold a meeting of the Board of Directors of the Company on 16 July 2026.

The board of Asian Hotels (East) at the meeting held on 9th July 2026 has not recommended any dividend for the financial year ended 31st March, 2026.

Asian Paints has appointed Sudhir Sitapati (DIN: 09197063) as an Additional and Independent Director of the Company for a term of five (5) consecutive years commencing from 29 May 2026 to 28 May 2031.

Aurobindo Pharma announced that PT Aurogen Pharma Indonesia, a wholly owned stepdown subsidiary of the Company, has incorporated a new wholly owned subsidiary company by the name of PT Auro Pharm Indonesia, in Indonesia.

The object of incorporation of this wholly owned step down subsidiary is to undertake manufacturing operations in Indonesia.